Medicine related research includes numerous studies on the hazards of mortality and what risk factors are associated with these hazards. From these observations, inferences can be made about the underlying population and consequently inform medical guidelines for intervention.
New health interventions are usually based on these estimated hazards obtained from clinical trials. A lengthy lead time would be needed to observe their effect on population longevity.
In this sessional Professor Elena Kulinskaya will discuss her paper How Medical Advances and Health Interventions Will Shape Future Longevity which shows how estimated mortality hazards can be translated to hypothetical changes in life expectancies at the individual and population levels. The required calculations are illustrated by two examples of medical interventions and their impact on life expectancy, which are beta blockers in heart attack survivors and blood pressure treatment in hypertensive patients. The second example also illustrates the dangers of applying the results from clinical trials to much wider real life populations.
Speakers: Professor Elena Kulinskaya, Research Programme Principal Investigator, University of East Anglia and Nigel Wright, Research Programme Co-investigator, Aviva
Contact Events Team for more information.
0207 632 1498
|19.00||Close of event|
This is an Actuarial Research Centre (ARC) sessional and is part of the Use of Big Health and Actuarial Data in Understanding Longevity and Morbidity Risks research programme.
Please note that this sessional will be both audio and video recorded.
The Royal College of Physicians of Edinburgh, 9 Queen St, Edinburgh EH2 1JQ
Nearest Public Transport